May 31, 2013
1 min read

Cross-linking for keratoconus improves long-term visual acuity, refraction, topography

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Corneal collagen cross-linking successfully halted the progression of keratoconus for up to 4 years or more, according to a study.

Investigators analyzed 30 patients with early to moderate keratoconus who underwent unilateral corneal collagen cross-linking with riboflavin and ultraviolet A 4 years to 6 years previously. Mean age at the time of cross-linking was 26.3 years; the mean interval between cross-linking and clinical evaluation was 53.3 months.

From before treatment out to 4 years to 6 years, mean spherical equivalent refractive error and corrected distance visual acuity improved significantly; mean simulated keratometry, cone apex power, root mean square, coma, secondary astigmatism and pentafoil decreased significantly.

From 1-year results out to 4 years to 6 years, mean simulated keratometry, cone apex power, root mean square, coma and secondary astigmatism decreased significantly; central pachymetry increased significantly.

No treated eyes had progression of keratoconus and none lost more than one line of corrected distance visual acuity; keratoconus progressed in seven untreated fellow eyes, the authors said.